Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 8.8% in December

Cibus, Inc. (NASDAQ:CBUS) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 2,230,000 shares, a growth of 8.8% from the November 30th total of 2,050,000 shares. Based on an average daily volume of 168,500 shares, the days-to-cover ratio is currently 13.2 days. Currently, 11.9% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of research firms have recently commented on CBUS. Alliance Global Partners dropped their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research report on Tuesday, September 24th. HC Wainwright reiterated a “buy” rating and issued a $25.00 target price on shares of Cibus in a research note on Monday, November 11th. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $20.00 target price on shares of Cibus in a research report on Tuesday, October 22nd.

Cibus Stock Up 7.8 %

Shares of NASDAQ CBUS opened at $2.78 on Thursday. Cibus has a 12 month low of $2.35 and a 12 month high of $23.18. The company has a market cap of $73.55 million, a P/E ratio of -0.12 and a beta of 1.86. The business’s 50 day moving average is $4.01 and its two-hundred day moving average is $5.81.

Hedge Funds Weigh In On Cibus

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new stake in Cibus in the 3rd quarter valued at $33,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of Cibus during the third quarter valued at about $44,000. Virtu Financial LLC bought a new stake in shares of Cibus in the third quarter valued at about $48,000. HighTower Advisors LLC grew its position in Cibus by 20.6% during the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after buying an additional 2,750 shares in the last quarter. Finally, Barclays PLC increased its stake in Cibus by 287.2% during the third quarter. Barclays PLC now owns 20,269 shares of the company’s stock valued at $66,000 after acquiring an additional 15,034 shares during the period. Institutional investors own 33.81% of the company’s stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.